DISORDER AND CURE

Four decades have passed since the first cases of what we now know as HIV/AIDS were reported, and yet the psychological landscape surrounding this diagnosis remains as complex and layered as ever. While medical advances in 2025 have transformed HIV from a death sentence into a manageable chronic condition, the emotional and social terrain that people with HIV must navigate continues to present profound challenges that extend far beyond the realm of physical health. The journey of living with HIV begins not with the virus itself, but with the moment of diagnosis—a psychological watershed that fundamentally alters one's relationship with their own body, their future, and their place in the world. This moment carries within it the weight of decades of stigma, fear, and misinformation that have accumulated around HIV since the early 1980s. Despite remarkable medical progress, including the development of long-acting injectable medications that have simplified treatment regimens, the p...

Lung cancer continues to represent one of the most challenging battles in modern oncology, claiming more lives globally than any other form of cancer. However, the medical landscape is experiencing a revolutionary transformation through precision medicine approaches. The revolutionary regulatory clearance of telisotuzumab vedotin (Emrelis) by the FDA in May 2025 demonstrates this transformative approach to cancer care, providing precision therapy for individuals whose tumors exhibit elevated c-Met protein levels and delivering remarkable 35% therapeutic response rates among patients who had received prior treatments. This cutting-edge therapeutic intervention is specifically designed to combat non-small-cell lung cancer (NSCLC), a cancer subtype that accounts for roughly 85% of all lung cancer cases worldwide. As we explore this comprehensive overview, we'll examine how precision medicine is reshaping treatment strategies and providing renewed hope for patients and their families...

Tuberculosis has reclaimed its position as the world's deadliest infectious disease, surpassing COVID-19 with approximately 1.25 million deaths in 2023. This ancient disease, which has plagued humanity for millennia, continues to evolve and challenge global health systems despite being both preventable and curable. The resurgence of TB as the leading infectious killer represents not just a medical crisis, but a complex intersection of social, economic, and psychological factors that demand our urgent attention. The Numbers Tell a Sobering Story The World Health Organization's 2024 Global Tuberculosis Report revealed that approximately 8.2 million people were newly diagnosed with TB in 2023—the highest number recorded since WHO began global TB monitoring in 1995. Year Estimated TB Cases Key Points 2022 7.5 million Baseline year for comparison 2023 10.8 million Significant increase in TB cases Top 5 High-Burden Countries (2023) % of Global TB Burden India 26% Indonesia 10% China...